Melan-A-IL-12 (Genetics Institute)

N/A

Report date: 2022/02/21 14:45:35

Base Information

Drug NameMelan-A-IL-12 (Genetics Institute)

Drug Alias NameN/A

ClassificationVaccines > Application > Therapeutic vaccine

Mechanisms of ActionInterleukin-12 receptor stimulants

TargetsInterleukin-12 receptor

Therapy Area/IndicationsMelanoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesPfizer Inc

Active IndicationsN/A

Inactive IndicationsMelanoma

ATC CodeN/A